Abstract:Background: It has been demonstrated that the expression of prostate-specific antigen (PSA) is known to not be organ or gender specific but rather a steroid hormone mediated response, and the level of PSA is elevated in the serum of women with hyperandrogenic syndromes. The urinary profile of PSA in female subjects is less clear. We investigated the expression of urinary PSA in female subjects with Cushing's syndrome and the relationship between urinary PSA and 2 steroid hormonal metabolites, 17-hydroxycorticosteroids (17-OHCS) and 17-ketosteroids (17-KS).Methods: We classified 97 female patients into 1 of 3 groups: Group A (n=37), patients with Cushing's syndrome (n=30), or adrenocortical hyperplasia (n=7); Group B (n=29), patients with primary hyperaldosteronism (n=18) or pheochromocytoma (n=11); and Group C (n=31), patients with non-adrenal diseases, including hypertension (n=12) and Type 2 diabetes (n=19). Patients with Cushing's syndrome or primary hyperaldosteronism were defined by clinical symptoms and laboratory confirmation. Patients with pheochromocytoma were defined by clinical symptoms, laboratory confirmation, and computed tomography or MRI. Patients with non-adrenal diseases were defined by a serum cortisol and plasma adrenocorticotropic hormone (ACTH) level within normal limits. Patients taking any medications in this category were excluded. Biochemical indicators related to the steroid hormonal metabolism, such as 17-OHCS, 17-KS, PSA, and creatinine (Cre) of 24-hour urine in these subjects were measured. The 17-OHCS, 17-KS, and PSA were all adjusted for 24-hour urinary Ore.Results: The 24-hour urinary PSA levels were significantly higher (P<0.0001) in the female patients with Cushing's syndrome (mean +/- SE=17.52 +/- 2.10 mu g/mol Ore) than in the controls (mean +/- SE=4.65 +/- 1.23 mu g/mol Ore). Similarly, there was also a significant difference (P<0.01) between 24-hour urinary 17-KS of the female patients (mean +/- SE=7.17 +/- 0.59 mmol/mol Ore) and the controls (6.17 +/- 0.55 mmol/mol Ore). A correlation was observed between 24-hour urinary PSA level and 24-hour urinary 17-KS concentration (rs=0.720, P<0.01). In Group A, the area under the curve (AUC) value of PSA (0.853, P<0.001) was greater than that of 17-OHCS (0.811, P<0.001) and 17-KS (0.693, P<0.01), respectively. In Group B, the AUC value of PSA (0.722, P<0.01) was greater than that of 17-OHCS (0.663, P>0.01) and 17-KS (0.632, P>0.01), respectively.Conclusions: Urinary PSA was elevated in female patients with Cushing's syndrome. It indicates that urinary PSA may be an additional parameter for a better definition of female " patients suffering from Cushing's syndrome.

Sex-related differences in Cushing's disease: a systematic review and meta-analysis

Gender-Specific Differences in Clinical Profile and Biochemical Parameters in Patients with Cushing’s Disease: A Single Center Experience

Gender and magnetic resonance imaging classification-related differences in clinical and biochemical characteristics of Cushing's disease: a single-centre study

Comparison of clinical, hormonal, pathological and treatment outcomes of ectopic Cushing's syndrome by sex: results of a multicenter study

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

Urinary Prostate-Specific Antigen is Elevated in Female Patients with Cushing'S Syndrome

Gender as an Independent Risk Factor for the Components of Metabolic Syndrome Among Individuals Within the Normal Range of Body Mass Index

Sex differences in cortisol levels in depression: A systematic review and meta-analysis

Sex difference in outcomes and management of cardiogenic shock: A systematic review and meta-analysis

Metabolic Profile Differences in ACTH-dependent and ACTH-independent Cushing Syndrome

Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review

Effectiveness of medical treatment for Cushing’s syndrome: a systematic review and meta-analysis

The conundrum of differentiating Cushing's syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis

Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults

Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta-Analysis

Effect of age factor on the clinical characteristics of Cushing's disease: a related research

Cushing Syndrome: A Review

Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment

Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses

Diagnostic dilemma in Cushing's syndrome: discrepancy between patient-reported and physician-assessed manifestations

Androgens in Cushing's Syndrome